Overexpression of ST6GAL1 gene enhances the chemoresistance of K562 cells both in vitro and in vivo. by Hongye Ma (424073)

“…The reported values are the IC₅₀ (Mean ± SD) of three independent experiments. …”

Fos does not interact with Jun but homodimerizes post axotomy. by Gibarni Mahata (19486154)

Datasheet1_Age-related reference intervals for ambulatory electrocardiographic parameters in healthy individuals.docx by Kenichi Hashimoto (12904415)

“…Multivariate analysis revealed that aging was the only independent significant factor influencing the frequency of VE (β = 0.207, P = 0.001). Age (β = 0.642, P < 0.001), body mass index (BMI) (β = −0.112, P = 0.009), and the root mean square of successive differences in RR intervals (β = 0.097, P = 0.035) were factors significantly associated with SVE frequency.…”

Supplementary Material for: Finerenone in Patients with Chronic Kidney Disease and Type 2 Diabetes: FIDELIO-DKD subgroup from China by Zhang H. (2945919)

“…The key secondary composite outcome included death from cardiovascular causes, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for heart failure. Results: After a median follow-up of 30 months, the finerenone group showed a relative risk reduction (RRR) of 41% (hazard ratio [HR]=0.59, 95% confidence interval [CI], 0.39 to 0.88; p=0.009) for the primary composite outcome compared with placebo, consistent across its components with treatment benefits with finerenone. …”

Supplementary Material for: Finerenone in Patients with Chronic Kidney Disease and Type 2 Diabetes: FIDELIO-DKD subgroup from China by Zhang H. (2945919)

“…The key secondary composite outcome included death from cardiovascular causes, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for heart failure. Results: After a median follow-up of 30 months, the finerenone group showed a relative risk reduction (RRR) of 41% (hazard ratio [HR]=0.59, 95% confidence interval [CI], 0.39 to 0.88; p=0.009) for the primary composite outcome compared with placebo, consistent across its components with treatment benefits with finerenone. …”

Supplementary Material for: Finerenone in Patients with Chronic Kidney Disease and Type 2 Diabetes: FIDELIO-DKD subgroup from China by Zhang H. (2945919)

“…The key secondary composite outcome included death from cardiovascular causes, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for heart failure. Results: After a median follow-up of 30 months, the finerenone group showed a relative risk reduction (RRR) of 41% (hazard ratio [HR]=0.59, 95% confidence interval [CI], 0.39 to 0.88; p=0.009) for the primary composite outcome compared with placebo, consistent across its components with treatment benefits with finerenone. …”

Supplementary Material for: Finerenone in Patients with Chronic Kidney Disease and Type 2 Diabetes: FIDELIO-DKD subgroup from China by Zhang H. (2945919)

“…The key secondary composite outcome included death from cardiovascular causes, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for heart failure. Results: After a median follow-up of 30 months, the finerenone group showed a relative risk reduction (RRR) of 41% (hazard ratio [HR]=0.59, 95% confidence interval [CI], 0.39 to 0.88; p=0.009) for the primary composite outcome compared with placebo, consistent across its components with treatment benefits with finerenone. …”

Supplementary Material for: Finerenone in Patients with Chronic Kidney Disease and Type 2 Diabetes: FIDELIO-DKD subgroup from China by Zhang H. (2945919)

“…The key secondary composite outcome included death from cardiovascular causes, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for heart failure. Results: After a median follow-up of 30 months, the finerenone group showed a relative risk reduction (RRR) of 41% (hazard ratio [HR]=0.59, 95% confidence interval [CI], 0.39 to 0.88; p=0.009) for the primary composite outcome compared with placebo, consistent across its components with treatment benefits with finerenone. …”

Zinc availability regulates the lifespan of <i>C</i>. <i>elegans</i>. by Jitendra Kumar (144555)

Self-report of psychological symptoms in hypoparathyroidism patients on conventional therapy by Amanda J. Arneiro (5256824)

Data Sheet 1_Effect of levothyroxine on major adverse cardiovascular events in patients with hypothyroidism and cardiovascular disease.docx by Lijia Liu (706103)

“…Compared to those not treated with levothyroxine, patients receiving levothyroxine showed a significantly reduced risk of 3P-MACE (HR, 0.67; 95% CI, 0.55–0.82, p < 0.01), all-cause death (HR, 0.24; 95% CI, 0.16–0.35, p < 0.01), all-cause hospitalization (HR, 0.23; 95% CI, 0.21–0.26, p < 0.01), and cardiovascular-related hospitalization (HR, 0.69; 95% CI, 0.59–0.82, p < 0.01).…”

Protective Role of Sirtuin3 (SIRT3) in Oxidative Stress Mediated by Hepatitis B Virus X Protein Expression by Ji-Hua Ren (3181890)

Image_1_Cooperation of arbuscular mycorrhizal fungi and bacteria to facilitate the host plant growth dependent on soil pH.PDF by Zengwei Feng (6583163)

“…Results showed that shoot biomass was the highest in the native soil, while both the decrease and increase in the soil pH reduced the biomass. …”

Table_1_Cooperation of arbuscular mycorrhizal fungi and bacteria to facilitate the host plant growth dependent on soil pH.DOCX by Zengwei Feng (6583163)

“…Results showed that shoot biomass was the highest in the native soil, while both the decrease and increase in the soil pH reduced the biomass. …”

Supplemental Figure 1 by lsimo2@lsuhsc.edu lsimo2@lsuhsc.edu (6704447)

“…There was a main effect of OVX to decrease HOMA-β at study endpoint. …”

Physostigmine (5 nM) effect on morphological defenses in dependence of <i>Chaoborus</i> and <i>Gasterosteus</i> kairomone (Bonferroni-corrected Mann-Whitney U comparison). by Linda C. Weiss (165793)

The integrative plot of the metabolites and the relevant pathways changing for thyroidectomy-induced hypothyroidism in circulation system. by Si Wu (154794)

Relative importance – conditional forest regression. by Akemi Tomoda (292280)

Histological grading of liver injury. by Shaza H. Aly (9276353)

“…In addition, it demonstrated a 68% decrease in lipid peroxide levels compared to the group with paracetamol-induced condition. …”

Estimates of model coefficients for association between treatments and main outcomes. by Martin Modrák (5101439)